Managing autoimmune conditions like rheumatoid arthritis can be complex and challenging, with treatment options that may not work effectively for everyone. We leverage the cutting-edge PrismRA pharmacogenomic test to provide personalized care for autoimmune patients.
What is PrismRA?
PrismRA is an advanced blood test that uses pharmacogenomics to predict whether a patient is likely to respond to Tumor Necrosis Factor (TNF) inhibitor therapies. These therapies are among the most commonly prescribed treatments for autoimmune diseases, but they are not effective for everyone. PrismRA helps identify patients who may not benefit from TNF inhibitors, allowing for a more tailored treatment approach.
Why Choose PrismRA?
Who Can Benefit from PrismRA?
PrismRA is ideal for patients diagnosed with rheumatoid arthritis or other autoimmune conditions who are considering TNF inhibitor therapies or have had limited success with previous treatments.
How Does It Work?
Transforming Autoimmune Care with Precision Medicine
We are committed to integrating the latest advancements in functional and precision medicine. The PrismRA test empowers our patients to make informed decisions and achieve better health outcomes with treatments tailored to their unique needs.